Acquired epidermodysplasia verruciformis syndrome in HIV-infected patients: a systematic review
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03016-x ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Daniel Cuestas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de La Sabana, Campus Puente Común Km. 7, Autopista Norte de Bogotá, Chía, Colombia. daniel00515@hotmail.com. Hauptthemen laut MEDLINE: Epidermodysplasia Verruciformis, HIV Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad El Bosque.
Abstract (Originalsprache)
Congenital epidermodysplasia verruciformis (CEV) is a Genodermatosis linked to different inheritance patterns and mutations of the EVER1/TMC6 and EVER2/TMC8 genes. There is an acquired form (AEV) associated with immunodeficiency states, including human immunodeficiency virus (HIV) infection; however, the literature about AEV is limited and imprecise, so a systematic review was performed. A search of the main databases from 1975 to 2021 identified 126 studies, of which 80 met the inclusion criteria. The diagnosis of AEV is complex due to atypical manifestations and locations, it requires a mean follow-up of 7 years, and the lesions do not change with ART therapy, CD4 count, or viral load. Histopathological findings are variable depending on the location of the lesions. HPV 5 remains the serotype most frequently associated with AEV and CEV, although HPV 20 is more frequent than HPV 8 in AEV. Most treatments have low efficacy, the most described are glycolic acid 15%, 5-fluorouracil 5%, imiquimod 5%, and topical retinoids all of them in monotherapy or combined with cryotherapy. Other alternatives include topical cidofovir and systemic retinoids with variable results. The oncologic prognosis is still inconclusive; however, the development of squamous cell carcinoma and melanoma are frankly lower concerning CEV. This review opens new opportunities for future research. Additionally, we provide clear and useful key points for the practice of dermatologists and all professionals treating HIV patients around the world.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidad de La Sabana, Campus Puente Común Km. 7, Autopista Norte de Bogotá, Chía, Colombia. daniel00515@hotmail.com.
- Estudioderma - Dermatologic Investigation Center - Medical Research Area, Bogotá, Colombia. daniel00515@hotmail.com.
- Dermatology Department, Universidad el Bosque, Bogotá, Colombia. daniel00515@hotmail.com.
- Estudioderma - Dermatologic Investigation Center - Medical Research Area, Bogotá, Colombia.
- Universidad del Sinú, Cartagena, Colombia.
- Universidad de La Sabana, Campus Puente Común Km. 7, Autopista Norte de Bogotá, Chía, Colombia.
Förderung
- Universidad El Bosque
Zitieren
APA
Cuestas, D., Gómez, A., Neri Morales, C., Motta, A., Rolon, M., Suarez, S., & Polo, R. (2024). Acquired epidermodysplasia verruciformis syndrome in HIV-infected patients: a systematic review. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03016-x
Vancouver
Cuestas D, Gómez A, Neri Morales C, Motta A, Rolon M, Suarez S, et al. Acquired epidermodysplasia verruciformis syndrome in HIV-infected patients: a systematic review. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03016-x
BibTeX
@article{Cuestas2024,
author = {Cuestas, Daniel and Gómez, Alexa and Neri Morales, Constanza and Motta, Adriana and Rolon, Mariam and Suarez, Samanda and Polo, Rosa},
title = {Acquired epidermodysplasia verruciformis syndrome in HIV-infected patients: a systematic review},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03016-x}
}
EUVIMED